Filing Details
- Accession Number:
- 0001127602-19-027163
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-08-21 16:15:13
- Reporting Period:
- 2019-08-19
- Accepted Time:
- 2019-08-21 16:15:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 885590 | Bausch Health Companies Inc. | BHC | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1749623 | C. Mark Mckenna | 400 Somerset Corporate Blvd. Bridgewater NJ 08807 | President, Salix | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares, No Par Value | Disposition | 2019-08-19 | 10,773 | $21.83 | 20,756 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.82 to $21.845 per share. The Reporting Person will provide to the Commission, the Issuerand any stockholder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range provided in this footnote.
Billionaire Hedge Funds
